鼻咽癌综合治疗策略

曾雷 已出版文章查询
曾雷
本平台内已出版文章查询
1 卢泰祥 已出版文章查询
卢泰祥
本平台内已出版文章查询
lutx@mail.sysu.edu.cn
1

+ 作者地址

1510060,广州,中山大学肿瘤防治中心放疗科


0
  • 参考文献
  • 相关文章
  • 统计

[1] Muir CS;Waterhouse J;Mark T.Cancer incidence in five con-tinents:vol V.IARC Scientific Publications No.88[M].Lyon:Inter-national Agency for Research on Cancer,1987

[2] Parkin DM;Whelan SL;Feday J.Cancer incidence in five continents:vol ⅤⅢ.IARC Scientific Publication NO,155[M].Lyon:International Agency for Research on Cancer,2002

[3] Wolden SL;Zelefsky MJ;Kraus DH;Rosenzweig KE;Chong LM;Shaha AR;Zhang H;Harrison LB;Shah JP;Pfister DG .Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma.[J].Journal of Clinical Oncology,2001(4):1105-1110.

[4] Teo PM;Leung SF;Lee WY;Zee B .Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose-tumor-control relationship above conventional tumoricidal dose.[J].International Journal of Radiation Oncology, Biology, Physics,2000(2):445-458.

[5] Su,S.-F.;Han,F.;Zhao,C.;Chen,C.-Y.;Xiao,W.-W.;Li,J.-X.;Lu,T.-X. .Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone[J].International Journal of Radiation Oncology, Biology, Physics,2012(1):327-333.

[6] Chua DT;Sham JS;Kwong DL;Au GK .Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma.[J].Cancer,2003(1):74-80.

[7] Xiao WW;Han F;Lu TX .Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma.[J].International Journal of Radiation Oncology, Biology, Physics,2009(4):1070-1076.

[8] 易俊林,高黎,黄晓东,罗京伟,李素艳,肖建平,徐国镇.临床Ⅱ期鼻咽癌根治性常规分割放疗预后分析[J].中华放射肿瘤学杂志,2009(02):83-87.

[9] Chen QY;Wen YF;Guo L;Liu H;Huang PY;Mo HY;Li NW;Xiang YQ;Luo DH;Qiu F;Sun R;Deng MQ;Chen MY;Hua YJ;Guo X;Cao KJ;Hong MH;Qian CN;Mai HQ .Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.[J].Journal of the National Cancer Institute,2011(23):1761-1770.

[10] Baujat B;Audry H;Bourhis J;Chan AT;Onat H;Chua DT;Kwong DL;Al Sarraf M;Chi KH;Hareyama M;Leung SF;Thephamongkhol K;Pignon JP .Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.[J].International Journal of Radiation Oncology, Biology, Physics,2006(1):47-56.

[11] Zhang L;Zhao C;Ghimire B et al.The role of concurrent chemora-diotherapy in the treatment of locoregionally advanced nasopharyn-geal carcinoma among endemic population:a meta-analysis of the phase Ⅲ randomized trials[J].BMC Cancer,2010,10:558-567.

[12] Chua,DT;Sham,JS;Choy,D;Lorvidhaya,V;Sumitsawan,Y;Thongprasert,S;Vootiprux,V;Cheirsilpa,A;Azhar,T;Reksodiputro,AH .Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal car[J].Cancer,1998(11):2270-2283.

[13] Ma J;Mai HQ;Hong MH;Min HQ;Mao ZD;Cui NJ;Lu TX;Mo HY .Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.[J].Journal of Clinical Oncology,2001(5):1350-1357.

[14] Chua DT;Ma J;Sham JS;Mai HQ;Choy DT;Hong MH;Lu TX;Min HQ .Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.[J].Journal of Clinical Oncology,2005(6):1118-1124.

[15] Lin JC;Jan JS;Hsu CY;Liang WM;Jiang RS;Wang WY .Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.[J].Journal of Clinical Oncology,2003(4):631-637.

[16] Lin JC;Liang WM;Jan JS;Jiang RS;Lin AC .Another way to estimate outcome of advanced nasopharyngeal carcinoma-is concurrent chemoradiotherapy adequate?[J].International Journal of Radiation Oncology, Biology, Physics,2004(1):156-164.

[17] Chan AT;Teo PM;Ngan RK;Leung TW;Lau WH;Zee B;Leung SF;Cheung FY;Yeo W;Yiu HH;Yu KH;Chiu KW;Chan DT;Mok T;Yuen KT;Mo F;Lai M;Kwan WH;Choi P;Johnson PJ .Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.[J].Journal of Clinical Oncology,2002(8):2038-2044.

[18] Chan AT;Leung SF;Ngan RK;Teo PM;Lau WH;Kwan WH;Hui EP;Yiu HY;Yeo W;Cheung FY;Yu KH;Chiu KW;Chan DT;Mok TS;Yau S;Yuen KT;Mo FK;Lai MM;Ma BB;Kam MK;Leung TW;Johnson PJ;Choi PH;Zee BC .Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma.[J].Journal of the National Cancer Institute,2005(7):536-539.

[19] Al-Sarraf M;LeBlanc M;Giri PG et al.Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer:phase Ⅲ randomized Intergroup study 0099[J].International Journal of Radiation Oncology,Biology,Physics,1998,16(04):1310-1317.

[20] Lee AW;Lau WH;Tung SY;Chua DT;Chappell R;Xu L;Siu L;Sze WM;Leung TW;Sham JS;Ngan RK;Law SC;Yau TK;Au JS;O'Sullivan B;Pang ES;O SK;Au GK;Lau JT .Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.[J].Journal of Clinical Oncology,2005(28):6966-6975.

[21] Chen,L.;Hu,C.-S.;Chen,X.-Z.;Hu,G.-Q.;Cheng,Z.-B.;Sun,Y.;Li,W.-X.;Chen,Y.-Y.;Xie,F.-Y.;Liang,S.-B.;Chen,Y.;Xu,T.-T.;Li,B.;Long,G.-X.;Wang,S.-Y.;Zheng,B.-M.;Guo,Y.;Mao,Y.-P.;Tang,L.-L.;Chen,Y.-M.;Liu,M.-Z.;Ma,J. .Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: A phase 3 multicentre randomised controlled trial[J].The lancet oncology,2012(2):163-171.

[22] Rossi A;Molinari R;Boracchi P et al.Adjuvant chemotherapy with vincristine,cyclophosphamide and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer:results of a 4 year multi-center randomized study[J].Journal of Clinical Oncology,1988,6(09):1401-1410.

[23] Chi KH;Chang YC;Guo WY;Leung MJ;Shiau CY;Chen SY;Wang LW;Lai YL;Hsu MM;Lian SL;Chang CH;Liu TW;Chin YH;Yen SH;Perng CH;Chen KY .A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients.[J].International Journal of Radiation Oncology, Biology, Physics,2002(5):1238-1244.

[24] Chan AT;Hsu MM;Goh BC;Hui EP;Liu TW;Millward MJ;Hong RL;Whang Peng J;Ma BB;To KF;Mueser M;Amellal N;Lin X;Chang AY .Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.[J].Journal of Clinical Oncology,2005(15):3568-3576.

[25] Bonner JA;Harari PM;Giralt J;Azarnia N;Shin DM;Cohen RB;Jones CU;Sur R;Raben D;Jassem J;Ove R;Kies MS;Baselga J;Youssoufian H;Amellal N;Rowinsky EK;Ang KK .Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.[J].The New England journal of medicine,2006(6):567-578.

[26] Lu TX;Zhao C;Chen L et al.An open,multicenter clinical study on cetuximab combined with intensity modulated radiotherapy(IMRT)plus concurrent chemotherapy in nasopharyngeal carcinoma(NPC):Preliminary repotr[J].Journal of Clinical Oncology,2010,28(15):7s.

[27] 黄晓东,易俊林,高黎,徐国镇,金晶,杨伟志,卢泰祥,吴少雄,吴仁端,胡伟汉,谢伟长,韩非,高远红,高剑铭,潘建基,陈传本,朗锦义,李涛,董昱,付玉彬,樊林,李柏森,黎静,王晓怀,陈炳旭,高献书,张萍,吴湘玮,胡炳强.抗表皮生长因子受体单克隆抗体h-R3联合放疗治疗晚期鼻咽癌的Ⅱ期临床研究[J].中华肿瘤杂志,2007(03):197-201.

[28] Lee,N.Y.;Zhang,Q.;Pfister,D.G.;Kim,J.;Garden,A.S.;Mechalakos,J.;Hu,K.;Le,Q.T.;Colevas,A.D.;Glisson,B.S.;Chan,A.T.C.;Ang,K.K. .Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): A phase 2 multi-institutional trial[J].The lancet oncology,2012(2):172-180.



期刊热词
  • + 更多
  • 字体大小